Business Context and Reporting Period
This Form 8-K Current Report was filed by NanoViricides, Inc. (NNVC) on May 15, 2020. The filing reports a corporate governance event: the appointment of a new member to the Board of Directors.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on personnel changes and related agreements.
Material Changes
- Board Appointment: Effective May 15, 2020, the Board appointed Todd Rokita as a new director to serve until the next annual meeting of stockholders.
- Committee Assignments: Mr. Rokita was simultaneously appointed to the Board's Nomination Committee and Compensation Committee.
- Background: Mr. Rokita is a former U.S. Representative (2011-2019) and former Indiana Secretary of State (2003-2011). He currently serves as General Counsel and Vice President of External Affairs for Apex Benefits Group, Inc.
Guidance, Outlook, and Compensation
- Compensation: Mr. Rokita will receive the same compensation as other non-employee directors, consisting of annual cash compensation and equity awards. These amounts will be pro-rated to his appointment date.
- Agreements: The Company entered into a Director Retainer Agreement providing for indemnification and advancement of expenses to the maximum extent permitted by Nevada law.
- Outlook: The filing contains no financial guidance, management commentary on business outlook, or discussion of risks and contingencies.
Investor Verification Checklist
- Verify the pro-rated compensation structure for Mr. Rokita in the Company's 2019 Proxy Statement.
- Review the full text of the Director Retainer Agreement (Exhibit 10.1) for specific indemnification terms.
- Confirm the date of the next annual meeting of stockholders to determine the end of Mr. Rokita's initial term.
- Check for any potential conflicts of interest given Mr. Rokita's roles with other entities (e.g., Apex Benefits Group, WishBone Medical, Acel 360).